Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial.
Anna-Maria Hoffmann-VoldHåvard H FretheimVikas K SarnaImon BaruaMaylen N CarstensOliver DistlerZsuzsanna H McMahanElizabeth R VolkmannØyvind MidtvedtHenriette DidriksenAlvilde DhainautAnne-Kristine HalseGunnstein BaklandMaiju PesonenInge OlsenØyvind MolbergPublished in: BMJ open (2021)
V.3.1.
Keyphrases
- phase ii
- systemic sclerosis
- clinical trial
- interstitial lung disease
- open label
- phase iii
- endothelial cells
- study protocol
- microbial community
- wastewater treatment
- placebo controlled
- double blind
- induced pluripotent stem cells
- randomized controlled trial
- sewage sludge
- cell therapy
- rheumatoid arthritis
- risk assessment
- idiopathic pulmonary fibrosis
- heavy metals